Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

RSLS

ReShape Lifesciences Inc.

Apr 17 • 04:00PM ET

0.1640

Dollar change +0.0025
Percentage change 1.55	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.73	Insider Own	11.27%	Shs Outstand	23.46M	Perf Week	-1.68%
Market Cap	3.85M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.02%	Shs Float	20.81M	Perf Month	0.24%
Income	-11.39M	PEG	-	EPS next Q	-0.88	Inst Own	1.97%	Short Float	3.50%	Perf Quarter	-27.43%
Sales	8.68M	P/S	0.44	EPS this Y	-	Inst Trans	-46.71%	Short Ratio	1.17	Perf Half Y	-49.37%
Book/sh	0.28	P/B	0.58	EPS next Y	-	ROA	-103.56%	Short Interest	0.73M	Perf Year	-94.76%
Cash/sh	0.19	P/C	0.84	EPS next 5Y	-	ROE	-220.59%	52W Range	0.14 - 4.10	Perf YTD	-34.32%
Dividend Est.	-	P/FCF	-	EPS past 5Y	76.96%	ROI	-167.11%	52W High	-96.00%	Beta	0.33
Dividend TTM	-	Quick Ratio	1.74	Sales past 5Y	32.13%	Gross Margin	63.93%	52W Low	15.98%	ATR (14)	0.01
Dividend Ex-Date	-	Current Ratio	2.73	EPS Y/Y TTM	96.57%	Oper. Margin	-168.68%	RSI (14)	44.86	Volatility	4.73% 8.02%
Employees	31	Debt/Eq	0.04	Sales Y/Y TTM	-22.79%	Profit Margin	-131.22%	Recom	1.00	Target Price	1.00
Option/Short	No / Yes	LT Debt/Eq	0.02	EPS Q/Q	99.80%	Payout	-	Rel Volume	0.39	Prev Close	0.16
Sales Surprise	-10.21%	EPS Surprise	15.00%	Sales Q/Q	-36.27%	Earnings	Nov 08 AMC	Avg Volume	622.11K	Price	0.16
SMA20	-4.64%	SMA50	-4.43%	SMA200	-68.14%	Trades		Volume	243,785	Change	1.55%

Apr-01-24 04:05PM	ReShape Lifesciences Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update (GlobeNewswire) -11.82%
Mar-28-24 08:31AM	ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System (GlobeNewswire)
Mar-04-24 08:31AM	ReShape Lifesciences Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band 2.0 FLEX (GlobeNewswire) -5.75%
Feb-22-24 08:31AM	ReShape Lifesciences Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 FLEX (GlobeNewswire)
Jan-24-24 08:31AM	ReShape Lifesciences Conducts Bariatric Fellows Training for its Lap-Band System, Highlighting the Next-Generation Lap-Band 2.0 FLEX (GlobeNewswire) -5.18%
07:00AM	Loading…
Dec-21-23 07:00AM	ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex (News Direct)
Dec-20-23 08:31AM	ReShape Lifesciences Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives (GlobeNewswire)
Dec-13-23 09:49AM	Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today? (InvestorPlace) +53.15%
Dec-12-23 04:05PM	ReShape Lifesciences Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band 2.0 FLEX (GlobeNewswire)
Nov-21-23 08:06AM	ReShape Lifesciences Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds (GlobeNewswire) -10.00%
Nov-12-23 12:52PM	ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 04:05PM	ReShape Lifesciences Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan (GlobeNewswire)
Nov-06-23 08:31AM	ReShape Lifesciences to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update (GlobeNewswire) -5.71%
Oct-25-23 08:14AM	Why Is Reshape Lifesciences (RSLS) Stock Up 59% Today? (InvestorPlace) +21.54%
Sep-29-23 12:30PM	ReShape Lifesciences Announces Pricing of $3.0 Million Public Offering (GlobeNewswire) -23.18%
08:31AM	Loading…
Sep-22-23 08:31AM	ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI (GlobeNewswire)
Sep-21-23 08:31AM	ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System (GlobeNewswire) -9.33%
Sep-19-23 08:31AM	ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System (GlobeNewswire) -5.60%
Sep-14-23 08:31AM	ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Device (GlobeNewswire)
Aug-07-23 04:05PM	ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-03-23 04:05PM	ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update (GlobeNewswire)
Jun-29-23 08:31AM	ReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software (GlobeNewswire)
Jun-28-23 08:31AM	ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation Device at the ASMBS 2023 Annual Meeting (GlobeNewswire) -6.62%
Jun-26-23 04:05PM	ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0 (GlobeNewswire)
Jun-23-23 08:35AM	Life Science Investor Forum: Presentations Now Available for Online Viewing (GlobeNewswire) -6.67%
Jun-20-23 10:58AM	Life Science Investor Forum Agenda Announced for June 22nd (GlobeNewswire)
Jun-14-23 08:31AM	ReShape Lifesciences® to Participate in Investor and Industry Conferences in June (GlobeNewswire)
May-15-23 04:05PM	ReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-11-23 08:30AM	ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide Corporate Update (GlobeNewswire)
Apr-27-23 08:30AM	ReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation Device at the Keystone Symposia on Type 2 Diabetes (GlobeNewswire)
04:05PM	Loading…
Apr-25-23 04:05PM	ReShape Lifesciences® Reports Year Ended December 31, 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-20-23 08:30AM	ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market (GlobeNewswire) -8.04%
Apr-11-23 08:30AM	ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to its Obalon® Balloon System (GlobeNewswire) +16.98%
Mar-28-23 09:50PM	ReShape Lifesciences® To Delay Year Ended December 31, 2022 Earnings Release and Conference Call (GlobeNewswire) +12.03%
Mar-23-23 08:30AM	ReShape Lifesciences Announces Formation of International Scientific Advisory Board (GlobeNewswire)
Mar-22-23 08:30AM	ReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update (GlobeNewswire)
Mar-15-23 08:30AM	ReShape Lifesciences® to Present at the Q2 Virtual Investor Summit (GlobeNewswire)
Feb-08-23 12:07PM	ReShape Lifesciences Announces Closing of Upsized $10.2 Million Underwritten Public Offering (GlobeNewswire)
Feb-06-23 08:30AM	ReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering (GlobeNewswire) -59.21%
Dec-22-22 08:30AM	ReShape Lifesciences Announces 1-for-50 Reverse Stock Split Effective as of Commencement of Trading on December 23, 2022 (GlobeNewswire) +5.21%
Nov-14-22 07:30AM	ReShape Lifesciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-08-22 09:28AM	ReShape Lifesciences Announces $750,000 Registered Direct Offering (GlobeNewswire) -12.61%
Nov-07-22 01:22PM	ReShape Lifesciences to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update (GlobeNewswire) -6.00%
Nov-03-22 08:30AM	ReShape Lifesciences Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation Device at ObesityWeek® (GlobeNewswire)
Nov-02-22 09:11AM	ReShape Lifesciences to Present at the Q4 Investor Summit (GlobeNewswire)
Oct-31-22 08:30AM	ReShape Lifesciences Announces That the ASMBS and IFSO Have Issued Updated Guidelines on Indications for Metabolic and Bariatric Surgery, Including the Lap-Band® (GlobeNewswire)
Oct-25-22 08:30AM	ReShape Lifesciences Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation (DBSN) System in Peer Reviewed, Frontiers in NeuroScience (GlobeNewswire) +5.26%
Oct-20-22 08:30AM	ReShape Lifesciences Announces Release of a Positive Consensus Statement on Lap-Band® Use and Lap-Band® Aftercare Management by the American Society of Metabolic and Bariatric Surgery (ASMBS) (GlobeNewswire)
Sep-22-22 08:30AM	ReShape Lifesciences Awarded Phase I NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Device (GlobeNewswire)
Sep-14-22 08:30AM	ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference (GlobeNewswire)
Aug-23-22 08:30AM	ReShape Lifesciences Appoints Seasoned Sales and Marketing Executive, Nick Ansari, as Senior Vice President of Global Commercial Operations (GlobeNewswire) +5.06%
Aug-15-22 04:05PM	ReShape Lifesciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) +5.49%
Aug-10-22 04:30PM	ReShape Lifesciences to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Update (GlobeNewswire) -8.16%
12:05PM	ReShape Lifesciences Receives FDA 510(k) Clearance for the GIBI HD Calibration Tubes for use in Gastric and Bariatric Procedures (GlobeNewswire)
Jul-27-22 04:05PM	ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer (GlobeNewswire) -5.06%
Jun-17-22 08:30AM	ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds (GlobeNewswire)
May-26-22 08:30AM	ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare (GlobeNewswire) +11.25%
May-23-22 08:00AM	ReShape Lifesciences Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
May-19-22 08:30AM	ReShape Lifesciences Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards (GlobeNewswire)
May-16-22 08:30AM	ReShape Lifesciences to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update (GlobeNewswire)
Apr-26-22 08:30AM	ReShape Lifesciences to Present at the Q2 Investor Summit (GlobeNewswire) -7.26%
Mar-31-22 11:33AM	Earnings Update: ReShape Lifesciences Inc. (NASDAQ:RSLS) Just Reported And Analysts Are Trimming Their Forecasts (Simply Wall St.) -12.59%
Mar-28-22 04:05PM	ReShape Lifesciences Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update (GlobeNewswire)
Mar-24-22 08:30AM	ReShape Lifesciences Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band® (GlobeNewswire)
Mar-17-22 09:07AM	ReShape Lifesciences to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate Update (GlobeNewswire) +18.89%
Mar-09-22 08:30AM	ReShape Lifesciences to Participate in Investor Conferences in March (GlobeNewswire)
Jan-18-22 08:30AM	ReShape Lifesciences to Participate in the American Society for Metabolic and Bariatric Surgerys (ASMBS) Leadership Academy and re-UNITED Meeting January 19-22, 2022 in Las Vegas (GlobeNewswire)
Jan-13-22 08:30AM	ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operations (GlobeNewswire)
Dec-20-21 08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing (PR Newswire)
Dec-14-21 08:35AM	Virtual Conference for Life Sciences Companies Broadcast Live December 16th (PR Newswire)
Dec-09-21 12:19PM	Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th (PR Newswire) -5.45%
08:35AM	ReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on December 16th (PR Newswire)
Nov-16-21 08:30AM	ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign (GlobeNewswire)
Nov-11-21 08:30AM	ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results (GlobeNewswire)
Nov-08-21 08:30AM	ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021 (GlobeNewswire)
Nov-04-21 08:30AM	ReShape Lifesciences to Launch Line of ProCare Health® Supplements to Meet Consumers Nutritional Needs (GlobeNewswire)
Oct-19-21 08:30AM	ReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conference (GlobeNewswire)
Oct-12-21 08:00AM	ReShape Launches National Advertising Campaign for Flagship Product, Lap-Band® (GlobeNewswire)
Sep-23-21 08:00AM	ReShape Lifesciences Featured in BioTuesdays (GlobeNewswire)
Sep-13-21 08:00AM	ReShape Lifesciences to Host Exhibit at Bariatric Summit (GlobeNewswire)
Sep-09-21 08:30AM	ReShape Lifesciences to Present at Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit on September 20, 2021 (GlobeNewswire)
Aug-31-21 08:00AM	ReShape Lifesciences Appoints Al Diaz as Vice President of Operations and Research and Development (GlobeNewswire)
Aug-20-21 12:24PM	Is ReShape Lifesciences (NASDAQ:RSLS) Using Debt Sensibly? (Simply Wall St.)
Aug-16-21 08:00AM	ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update (ACCESSWIRE) -10.38%
Aug-05-21 08:00AM	ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update (ACCESSWIRE) +7.22%
Aug-03-21 08:00AM	ReShape Lifesciences(TM) CEO Bart Bandy Featured on the Big Biz Show (ACCESSWIRE) -7.69%
Jul-29-21 08:30AM	ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021 (ACCESSWIRE)
Jul-13-21 08:30AM	ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress (ACCESSWIRE) -7.84%
Jul-07-21 08:30AM	ReShape Lifesciences Moves Lap-Band Manufacturing to United States (ACCESSWIRE)
Jul-01-21 08:30AM	ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis (ACCESSWIRE)
Jun-30-21 08:30AM	ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders (ACCESSWIRE) -9.42%
Jun-29-21 09:27AM	ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds (ACCESSWIRE) -27.75%
Jun-17-21 08:45AM	ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market (ACCESSWIRE) -6.51%
Jun-16-21 07:30AM	ReShape Lifesciences Completes Merger with Obalon Therapeutics (ACCESSWIRE) -31.15%
Jun-15-21 12:05PM	ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger (ACCESSWIRE) -5.86%
Jun-08-21 07:30AM	ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger (ACCESSWIRE)
May-24-21 07:30AM	Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences (ACCESSWIRE) +14.04%
May-21-21 07:30AM	Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences (ACCESSWIRE) +30.04%
May-18-21 07:30AM	Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021 (ACCESSWIRE) +22.03%
May-17-21 04:05PM	ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results (ACCESSWIRE)

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STANKOVICH THOMAS	Chief Financial Officer	Oct 25 '23	Sale	0.27	131	35	22,949	Nov 08 04:16 PM
STANKOVICH THOMAS	Chief Financial Officer	Oct 11 '23	Sale	0.93	39	36	23,080	Nov 08 04:16 PM
STANKOVICH THOMAS	Chief Financial Officer	Sep 01 '23	Sale	0.89	118	105	23,119	Nov 08 04:16 PM
STANKOVICH THOMAS	Chief Financial Officer	Aug 24 '23	Sale	1.42	39	55	23,237	Nov 08 04:16 PM
STANKOVICH THOMAS	Chief Financial Officer	Aug 04 '23	Sale	1.43	108	154	23,276	Nov 08 04:16 PM
STANKOVICH THOMAS	Chief Financial Officer	Jul 06 '23	Sale	1.47	106	156	23,384	Jul 19 04:07 PM
STANKOVICH THOMAS	Chief Financial Officer	Jun 30 '23	Buy	1.52	17,702	26,907	23,490	Jul 06 04:16 PM
STANKOVICH THOMAS	Chief Financial Officer	May 31 '23	Sale	2.41	98	236	5,788	Jul 06 04:16 PM
STANKOVICH THOMAS	Chief Financial Officer	Apr 30 '23	Sale	2.36	96	227	5,886	Jul 06 04:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RSLS

ReShape Lifesciences Inc.

Upgrade your FINVIZ experience